Payden & Rygel’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-211,600	Closed	-$9.74M	–	115
2016 Q3	$9.74M	Buy	+211,600	New	+$9.74M	0.98%	43
2016 Q1	–	Sell	-762	Closed	-$50K	–	203
2015 Q4	$50K	Buy	+762	New	+$50K	0.01%	111